U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07090226) titled 'Diffuse Cutaneous Scleroderma (DSSc) SFDI Study' on July 21.
Brief Summary: Scleroderma (SSc) is an autoimmune disease characterized by fibrosis (or collagen deposition) of the skin and internal organs. The extent of skin fibrosis is an important predictor of internal organ complications and increased mortality. Currently a very imprecise, subjective method that varies amongst different doctors for the same patient is used to quantify skin fibrosis in patients, by "pinching" their skin and assessing how thick it is; this is the method used to determine the modified Rodnan skin score (mRSS).
A previous plot study was conducted by th...